Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company (vol 175, pg 1053, 2022)

Lalani

ANNALS OF INTERNAL MEDICINE, 2022; 175 (9):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索